Clinical Trial Update: A Dose Escalation Study of Bradanicline in Refractory Chronic Cough [Phase 2]

View source ↗

Summary

Phase 2 dose-escalation study of bradanicline in refractory chronic cough has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• bradanicline (bradanicline)

Snippet

Sponsor: Attenua, Inc. | Conditions: Chronic Cough | Phase 2 | Status: COMPLETED